Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Training Course in Preparing Stable Lyophilized Protein Formulations

Published: Tuesday, June 04, 2013
Last Updated: Tuesday, June 04, 2013
Bookmark and Share
New hands-on training course designed by Dr Jeff Schwegman and Dr John Carpenter.

SP Scientific has announced a new hands-on training course entitled 'Rapid and Rational Development of Stable Lyophilized Protein Formulations'.

Due to take place from September 17-20, 2013 the extended training course has been designed by renowned industry experts Dr Jeff Schwegman and Dr John Carpenter to provide valuable assistance to those involved in the development and manufacture of diagnostics, vaccines, and biologically based injectable drug products including monoclonal antibodies.

Today an increasing number of products being developed as vaccines, diagnostics, and injectable drugs are based upon biological molecules such asproteins, enzymes, and antibodies.

Companies involved in these markets use these molecules to develop testing kits to detect various disease states and their pre-cursers, to develop vaccines to prevent and or minimize infections and to develop protein based drugs, including monoclonal antibodies, to treat disease states in both humans and animals.

While discovery and development of these types of products has soared, traditional downstream development methodologies used in formulation and stabilization are often failing to achieve long term stability, consequently companies may find themselves unable to manufacture their products to meet the guidelines laid out by the FDA.

Lyophilization, or freeze-drying, is recognized as a process used to enhance the stability of many products; however, if not done properly on biologically based formulations, it can be extremely damaging to the physical structure of the molecule, rendering them inactive, aggregated, and potentially eliciting an immune response in patients.

Addressing this issue, the 4-day training course has been designed to enable people involved with lyophilization, at all levels of experience, to gain considerable knowledge about the rapid and rational development of stable lyophilized protein formulations and to reinforce their classroom training with extensive laboratory work.

Full details of this extensive hands-on training course to be held in SP Scientific's modern Warminster, PA laboratory / training facility is available at www.spscientific.com/ProteinHandsOn.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sub-Visible Particles: Impact On Therapeutic Proteins
New LyoLearn webinar to run on 27th June 2013.
Friday, June 07, 2013
Methods for Evaluating Lyophilized Product
SP Scientific, a world leader in freeze drying technology, has announced a new LyoLearn webinar that will discuss standard methods for evaluating lyophilized products.
Tuesday, December 07, 2010
Scientific News
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Paper Filter Can Remove Viruses from Water
A new paper filter can purify water from viruses, even the most difficult and contagious.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Antibody Therapy Opens Door to Potential New Treatment for HIV
Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!